New Jersey: Want to participate in an Anti-Redness trial?

Written by on September 1, 2010 in clinical trials, New Rosacea Treatments, Sansrosa with 1 Comment

The recruiting manager from Frontage Clinical is looking for participants in the trial they are hosting for rosacea redness.

Frontage Clinical in Hackensack, NJ is conducting a research study to evaluate the safety of an investigational topical gel medication for moderate to severe facial redness associated with ROSACEA.

All qualified participants will receive at no cost evaluations by a certified physician, investigational gel medication and compensation for participating.

Must be 18 years or older and have been diagnosed with Rosacea.

Must contact Recruiting Department at (201) 678-0288 for further information

A reasonable guess is that this trial is for the Oxymetazoline based V-101 product from Vicept Therapeutics or the Phase II dose finding study for Sansrosa / CD07805/47. Perhaps there is some clue in that Sansrosa is called a gel and V-101 is called a cream, tipping me to guess that this the Sansrosa trial.

Regardless of the topical in question, I would expect that a lab involved in any trial will keep the product and client close to their chests in the interests of keeping blind tests blind.

If anyone is available then please do join the program so that a new treatment for the redness of rosacea can progress closer to possible availability.

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed Connect on Pinterest Connect on Google Plus

1 Reader Comment

  1. Alison N says:

    Just an FYI – I just called and this trial has been cancelled.

Leave your comment here

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.